{
  "docId": "019de075-c3df-7648-ab3f-403a3e018886",
  "docSlug": "132267474e075f06292187997a008f90",
  "documentTitle": "OmniAb | Investor Presentation Deck | 35 slides",
  "authorId": "omniab",
  "authorName": "OmniAb",
  "documentKindSlug": "pitchdeck",
  "documentKindLabel": "Pitch deck",
  "sourceTypeSlug": "investor_relations",
  "sourceTypeLabel": "Investor relations",
  "presentationDate": "2023-08-01 00:00:00",
  "orientation": "landscape",
  "aspectRatio": 1.7777778,
  "pageNumber": 19,
  "pageCount": 35,
  "prevPage": 18,
  "nextPage": 20,
  "slideType": "other",
  "function": "present_framework",
  "density": "balanced",
  "nDataPoints": 3,
  "notes": "The slide uses a hybrid layout combining a gallery of antibody structural diagrams with a pie chart representing market/clinical distribution.",
  "elementsJson": null,
  "metadataConfidence": 0.95,
  "imagePath": null,
  "slideHref": "/slides/019de075-c3df-7648-ab3f-403a3e018886/19",
  "deckHref": "/decks/019de075-c3df-7648-ab3f-403a3e018886",
  "deckJsonHref": "/decks/019de075-c3df-7648-ab3f-403a3e018886.json",
  "deckAnchorHref": "/decks/019de075-c3df-7648-ab3f-403a3e018886#slide-19",
  "components": [
    {
      "bbox": {
        "h": 0.55,
        "w": 0.45,
        "x": 0.45,
        "y": 0.3
      },
      "kind": "chart",
      "text": "Pie chart showing Multispecific (48%), Monospecific (48%), and ADC (4%)",
      "attrs": null,
      "subkind": "pie",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "92c6741c-7925-49a1-8ec7-df823f6527b8",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.45,
        "w": 0.45,
        "x": 0.06,
        "y": 0.35
      },
      "kind": "image",
      "text": "Gallery of antibody formats (Duobody, Fab-VHH, ADAPTIR, IgG-scFv, IgG-Anticalin, TRAAC, Fab-Fc/scFv-Fc-scFv, IgG, HexaBody)",
      "attrs": null,
      "subkind": "illustration",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "006c0a42-6a04-4bd1-b2ee-403783383904",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.05,
        "w": 0.45,
        "x": 0.04,
        "y": 0.86
      },
      "kind": "source-note",
      "text": "* Toll-like Receptor Agonist Antibody Conjugate (Tallac Therapeutics/ALX Oncology)",
      "attrs": null,
      "subkind": null,
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "23d68ec1-b760-4344-96a6-d14458aa8e80",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.15,
        "w": 0.92,
        "x": 0.04,
        "y": 0.05
      },
      "kind": "title",
      "text": "Diverse Formats and Modalities of Preclinical and Clinical Molecules",
      "attrs": null,
      "subkind": "headline",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "c031a7f3-2591-414d-aa0e-583fd61a6f5f",
      "frameworkName": null,
      "frameworkSlug": null
    }
  ],
  "metrics": [],
  "tools": [
    {
      "name": "Chart Selection Guide",
      "slug": "chart-selection-guide",
      "agent": "Designer",
      "layer": "slide",
      "matchId": "8ca6b618-b254-41f1-9c1c-ec230641f519",
      "evidence": "chart/pie: Pie chart showing Multispecific (48%), Monospecific (48%), and ADC (4%)",
      "confidence": 0.5
    },
    {
      "name": "Visual emphasis",
      "slug": "visual-emphasis",
      "agent": null,
      "layer": "slide",
      "matchId": "972f93e5-1841-435c-98d0-9932b7e2283f",
      "evidence": "image/illustration: Gallery of antibody formats",
      "confidence": 0.7
    }
  ],
  "frameworks": [],
  "arcBeats": [
    {
      "to": 22,
      "from": 11,
      "beatId": "6721206b-7fe9-4c7d-b20f-2a1cfb83cec2",
      "arcName": "The Sequoia Pitch",
      "arcSlug": "sequoia-pitch",
      "beatName": "Solution",
      "beatSlug": "sequoia-pitch-solution",
      "evidence": "The document presents OmniAb's platform and technology offering as a solution.",
      "position": 1,
      "confidence": 0.8,
      "parentBeatName": "Turn",
      "parentBeatSlug": "turn"
    }
  ],
  "loops": [
    {
      "to": 35,
      "from": 5,
      "name": "Cost Of Inaction",
      "slug": "27-cost-of-inaction",
      "bestFor": "Urgent budget requests, compliance, risk mitigation",
      "matchId": "1674fffb-efec-427e-b437-66fc0c0fd01e",
      "evidence": "The document presents the potential consequences of not investing in effective discovery technology.",
      "position": 0,
      "objective": "Highlight the importance of investing in OmniAb's technology to drive growth and success in the biotech industry.",
      "structure": "The Status Quo -> The Hidden Costs Accumulating -> The Future State of Inaction -> The Tipping Point",
      "confidence": 0.6,
      "description": "Quantify what happens if the audience does nothing"
    }
  ],
  "imagePathAlt": null,
  "thumbSrc": null,
  "thumbSrcAlt": null,
  "locked": true
}